FDA approves Lipfendra, a first-of-its-kind cholesterol pill
The FDA has approved Lipfendra, an oral medication from Merck that lowers cholesterol in a way previously only available with injectable therapies.
Merck will market Lipfendra, which is a first-of-its-kind pill that can reduce cholesterol in a way that’s previously only has been available with injectable drugs.